http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016168361-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e32caaf13eb3a6948a81d7792ef48f17
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-876
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-208
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-193
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1841
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001191
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00119
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001186
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
filingDate 2016-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_550200a965326de16232106ba0fe7822
publicationDate 2016-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2016168361-A1
titleOfInvention Polyvalent vaccines and combination therapy for the treatment of melanoma
abstract The present invention features a polyvalent vaccine for inducing an immune response and methods for treating patients with melanoma or preventing the recurrence of melanoma in patients in need. The vaccine can also be administered in combination with one or more active pharmaceutical ingredients, such as one or more checkpoint inhibitors. Also provided are methods for using and making the compositions.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018112360-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018112364-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113272330-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11359028-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10836830-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10844119-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11136404-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10882908-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10626181-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10259882-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020177627-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11332536-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11447557-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11472883-B2
priorityDate 2015-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014144885-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5882654-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4591572-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015134577-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010272676-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010040614-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423403
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8478
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7427
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408915
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122074
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5385498
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID451714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426437
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10224496
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396484
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396486
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31236
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411642
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5497144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406017
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID230280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226580945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11620162
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9920342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424659
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412729

Total number of triples: 89.